Ametek (AME) Reports In-Line Q1 EPS, FY Guidance Fall Short of Consensus
Get Alerts AME Hot Sheet
Price: $237.72 --0%
Revenue Growth %: +9.5%
Financial Fact:
Selling, general and administrative: 113.17M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.5%
Financial Fact:
Selling, general and administrative: 113.17M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Ametek (NYSE: AME) reported Q1 EPS of $0.57, in-line with the analyst estimate of $0.57. Revenue for the quarter came in at $944.4 million versus the consensus estimate of $966.27 million.
GUIDANCE:
Ametek sees FY2016 EPS of $2.42-$2.52, versus the consensus of $2.57.
- sales to be roughly flat versus last year
Ametek sees Q2 2016 EPS of $0.58-$0.59, versus the consensus of $0.65.
- sales are expected to be down low single digits
For earnings history and earnings-related data on Ametek (AME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Morgan Stanley Upgrades M&T Bank (MTB) to Overweight
- Solaris Energy raises 2026 guidance, initiates Q1 2027 outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share